Further IHC of BLCA patients demonstrated that high-grade tumors exhibited heightened CSPG4 expression (Fig. 7I, Appendix Fig. A7), aligning with our cohort analysis. The gene discussed is CSPG4; the disease is bladder transitional cell carcinoma.